NCT02414737View on ClinicalTrials.gov

Ovarian Stimulation Single Injection Elonva

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Infertility
Interventions
DRUG

corifollitrophin alfa

use of a single dose of corifollitrophin alfa to provide adequate controlled ovarian hyperstimulation during IVF treatment

Trial Locations (1)

5042

Flinders Fertility, Bedford Park

All Listed Sponsors
collaborator

Flinders University

OTHER

lead

Flinders Fertility

INDUSTRY

NCT02414737 - Ovarian Stimulation Single Injection Elonva | Biotech Hunter | Biotech Hunter